SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-22-012765
Filing Date
2022-12-19
Accepted
2022-12-19 18:50:35
Documents
2
Period of Report
2022-12-15

Document Format Files

Seq Description Document Type Size
1 form3-12192022_111221.html 3  
1 form3-12192022_111221.xml 3 1704
2 ex24-12192022_111221.htm EX-24 7044
  Complete submission text file 0001415889-22-012765.txt   10228
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address
Atadja Peter (Reporting) CIK: 0001958563 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 221472417